Skip to main content
. Author manuscript; available in PMC: 2020 Dec 15.
Published in final edited form as: Int J Cardiol. 2019 Oct 8;297:104–110. doi: 10.1016/j.ijcard.2019.09.052

Figure 2.

Figure 2.

Peak ICa-L response to intracellular administration of increasing concentrations of angiotensin peptides to SD and TGR(hAGT)L1623 cardiomyocytes. A, ICa-L density relative to maximum activation in response to increasing concentrations of intracellular Ang II; n=7-11 for each dose and group. B, ICa-L density relative to maximum activation in response to different concentrations of intracellular Ang-(1–12) ; n=6–10 for each dose and group. * denotes p < 0.05 compared to the same dose in SD control cardiomyocytes.